Latent Labs
@Latent_Labs
Frontier models for all molecules of life
Radical portfolio company @Latent_Labs unveils Latent-X, their frontier AI model. Co-founded by AlphaFold pioneer @saakohl, Latent Labs is making biology "programmable" to accelerate drug discovery. Learn more about Latent-X here: latentlabs.com/latent-x/
5 months from funding to shipping our first frontier model. Latent-X achieves state-of-the-art hit rates for macrocycles and mini-binders, with picomolar binding affinities — a breakthrough in de novo protein binder design. Available now on our no-code platform!
This team is cooking. Blog: latentlabs.com/latent-x/ Paper: latentlabs.com/wp-content/upl… X post: x.com/Latent_Labs/st…
5 months from funding to shipping our first frontier model. Latent-X achieves state-of-the-art hit rates for macrocycles and mini-binders, with picomolar binding affinities — a breakthrough in de novo protein binder design. Available now on our no-code platform!
We are sponsoring travel grants for US PhD students to attend ICML this year! Apply below or share on to students who might benefit from this!
University budgets everywhere are getting slashed, and we hear many PhD students with accepted ICML papers can no longer afford to attend. We are stepping in to offer travel grants for researchers who lost funding. Sponsored by Pillar VC, Ormoni Bio, Latent Labs, and Cimulate
🚀 Big milestone — impressive science and great to see it made so accessible. Congrats to the @Latent_Labs team!
Introducing Latent-X — our all-atom frontier AI model for protein binder design. State-of-the-art lab performance, widely accessible via the Latent Labs Platform. Free tier: platform.latentlabs.com Blog: latentlabs.com/latent-x/ Technical report: tinyurl.com/latent-X
Introducing Latent-X — our all-atom frontier AI model for protein binder design. State-of-the-art lab performance, widely accessible via the Latent Labs Platform. Free tier: platform.latentlabs.com Blog: latentlabs.com/latent-x/ Technical report: tinyurl.com/latent-X
I’ll be at the @FT Biotech Summit this Thursday in NY. Looking forward to the discussion with @glen_gowers, Michael Curtis, Amber Salzman, and @mroliverbarnes and meeting many of you there!
Excited to share nnInteractive: The nnU-Net moment for 3D Interactive Segmentation! Supports points, scribbles, boxes, & a new lasso prompt for full 3D masks from 2D inputs. Check it out: arxiv.org/abs/2503.08373 github.com/MIC-DKFZ/napar… mitk.org/wiki/MITK-nnIn…
"Latent Labs is building AI foundation models to 'make biology programmable', partnering with biotech and pharma to generate and optimize proteins." Huge thanks to @TechCrunch, @psawers, our investors & supporters - this is just the beginning. Follow us as we push the frontiers…
"What if scientists could create the building blocks of new medicines completely from scratch, targeting diseases with precisely designed cures? That is the vision of Latent Labs, a London- and San Francisco-based start-up, which is today announcing it has now raised $50 million…
"One of DeepMind’s Nobel-prize winning AlphaFold team has raised $50 million to launch his own venture designing new proteins, with the goal of “achieving computational mastery over biology”." Thank you @thetimes and @richardtyler for featuring us: thetimes.com/business-money… This…
"Simon Kohl, a scientist who helped build DeepMind’s protein prediction programme, which won the company’s co-founder a Nobel Prize, has raised $50M to launch a startup to discover new drugs." We’re grateful for the incredible response to our mission. Thank you @FT,…
We are out of stealth with $50M in funding. Join us on our moonshot mission of making biology programmable and reach out to work with us today.
@Latent_Labs comes out of stealth today with $50M funding. Our goal? To push the frontiers of generative biology, giving partners instant access to tools capable of accelerating drug design. Every biotech or pharma company searching for the best therapeutic molecules understands…